Key Takeaways
- • LaserAway, a US medspa and aesthetic dermatology operator backed by Ares Management and Seidler Equity Partners, is exploring a sale that could value the business at more than $2 billion, with Harris Williams advising on the process.
- • The company generates approximately $150 million in annual EBITDA, supported by recurring revenue from non-surgical cosmetic treatments including laser hair removal, tattoo removal, skin rejuvenation, and injectables, with pricing ranging from $99 to $649 per session.
- • Ares acquired a significant minority stake in LaserAway in 2021 when the company operated 74 clinics; the potential sale reflects sustained private equity interest in the medspa sector driven by resilient consumer spending on elective aesthetic procedures.
- • Recent competitive activity in the aesthetics space includes General Atlantic's take-private of European Wax Center, KKR's backing of SkinSpirit, Leonard Green & Partners' ownership of Milan Laser, and Stride Consumer Partners' investment in Peachy.
- • The transaction discussions remain in early stages and confidential, with no final decision made; all parties declined to comment on the process.
Summary
LaserAway, the Los Angeles-based medspa and aesthetic dermatology operator, is weighing a potential sale that could exceed $2 billion in enterprise value. The company, founded in 2006 by Dr. Roy Winston and brothers Scott, Todd, and Brock Heckmann, has engaged investment bank Harris Williams to advise on the transaction process, which sources indicate remains in preliminary stages. According to Reuters, discussions are confidential and no binding commitment has been reached.
The business is backed by Ares Management and Seidler Equity Partners. Ares initially invested in LaserAway in 2021 when the company operated 74 clinics. The company has expanded its footprint nationwide, offering a comprehensive menu of non-surgical cosmetic treatments, including laser hair removal, tattoo removal, skin rejuvenation services, and injectable treatments such as Botox. LaserAway's service pricing reflects competitive positioning, with laser hair removal sessions ranging from approximately $99 to $649 per treatment, supplemented by bundled packages and financing options.
The business demonstrates strong underlying economics, generating approximately $150 million in annual EBITDA, which reflects favorable unit margins supported by the recurring nature of cosmetic procedures and consistent consumer demand for elective aesthetic treatments. This financial profile has attracted sustained interest from the private equity community, which views the medspa sector as offering attractive characteristics including recurring revenue models and resilient consumer spending patterns even during economic uncertainty.
Recent transaction and investment activity underscores competitive dynamics in the aesthetics space. General Atlantic completed a take-private of European Wax Center, while KKR backed SkinSpirit, Leonard Green & Partners acquired Milan Laser, and Stride Consumer Partners invested in Peachy. This ecosystem activity reflects confidence among institutional investors in the durability and growth trajectory of the aesthetic dermatology sector. All parties involved in the LaserAway process—Ares, the company, Seidler Equity Partners, and Harris Williams—declined to comment when contacted.
The business is backed by Ares Management and Seidler Equity Partners. Ares initially invested in LaserAway in 2021 when the company operated 74 clinics. The company has expanded its footprint nationwide, offering a comprehensive menu of non-surgical cosmetic treatments, including laser hair removal, tattoo removal, skin rejuvenation services, and injectable treatments such as Botox. LaserAway's service pricing reflects competitive positioning, with laser hair removal sessions ranging from approximately $99 to $649 per treatment, supplemented by bundled packages and financing options.
The business demonstrates strong underlying economics, generating approximately $150 million in annual EBITDA, which reflects favorable unit margins supported by the recurring nature of cosmetic procedures and consistent consumer demand for elective aesthetic treatments. This financial profile has attracted sustained interest from the private equity community, which views the medspa sector as offering attractive characteristics including recurring revenue models and resilient consumer spending patterns even during economic uncertainty.
Recent transaction and investment activity underscores competitive dynamics in the aesthetics space. General Atlantic completed a take-private of European Wax Center, while KKR backed SkinSpirit, Leonard Green & Partners acquired Milan Laser, and Stride Consumer Partners invested in Peachy. This ecosystem activity reflects confidence among institutional investors in the durability and growth trajectory of the aesthetic dermatology sector. All parties involved in the LaserAway process—Ares, the company, Seidler Equity Partners, and Harris Williams—declined to comment when contacted.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.